STXK - ETF AI Analysis

Top Page

Strive 2000 ETF (STXK)

Rating:66Neutral

Price Target:―

STXK, the Strive 2000 ETF, has a solid overall rating, supported by strong holdings like Onto Innovation, Sanmina, and TTM Technologies, which benefit from healthy financial performance, positive earnings calls, and generally favorable technical trends. These strengths are partly offset by weaker names such as Arrowhead Pharmaceuticals and Uranium Energy, where financial instability and valuation concerns introduce more uncertainty. The main risk for this ETF is its exposure to several companies with high valuations and financial or profitability challenges, which could make returns more volatile.

Positive Factors

Strong Recent Performance

The ETF has shown solid gains over the year so far, with recent one- and three-month returns also trending positively.

Strong-Performing Top Holdings

Several of the largest positions, including companies in mining, technology, and digital infrastructure, have delivered strong year-to-date gains that support the fund’s overall results.

Low Expense Ratio

The fund’s expense ratio is relatively low, which helps investors keep more of the returns generated by the portfolio.

Negative Factors

Heavy U.S. Concentration

Almost all of the ETF’s assets are invested in U.S. companies, offering very limited geographic diversification.

Small Individual Position Sizes

Each top holding makes up a small slice of the portfolio, which can dilute the impact of even strong-performing stocks on overall returns.

Exposure to Volatile Sectors and Stocks

Holdings in areas like mining, biotech, and smaller technology names can be more volatile, and at least one top holding has shown weak year-to-date performance.

STXK vs. SPDR S&P 500 ETF (SPY)

AUM73.75M

RegionNorth America

Expense Ratio0.18%

Beta0.99

IssuerStrive

Inception DateNov 10, 2022

Dividend Yield1.23%

Asset ClassEquity

Index TrackedBloomberg US 600 Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume7,522

30 Day Avg. Volume10,171

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

41.19

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering591

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

STXK Summary

Strive 2000 ETF (STXK) is a fund that tracks the Bloomberg US 600 Index, focusing on small U.S. companies across many sectors like financials, technology, and health care. It holds a wide mix of stocks, including names like Hecla Mining Company and Guardant Health, so you’re not betting on just one industry. Investors might consider STXK if they want growth potential from smaller, up‑and‑coming businesses while still staying diversified. A key risk is that small-cap stocks can be more volatile than larger, more established companies, so the price can move up and down sharply.

How much will it cost me?The Strive 2000 ETF (Ticker: STXK) has an expense ratio of 0.18%, meaning you’ll pay $1.80 per year for every $1,000 invested. This is lower than average for actively managed funds, as it focuses on small-cap stocks with a broad-based approach while keeping costs relatively low for investors.

What would affect this ETF?The Strive 2000 ETF (STXK), with its focus on U.S. small-cap stocks across diverse sectors like technology, financials, and consumer cyclical, could benefit from economic growth and innovation in these industries, as smaller companies often thrive during expansion periods. However, small-cap stocks are more sensitive to economic downturns, interest rate hikes, and market volatility, which could negatively impact the ETF's performance. Additionally, regulatory changes or sector-specific challenges in areas like healthcare or energy could influence the fund's growth potential.

STXK Top 10 Holdings

STXK’s story is classic small-cap: a few fast climbers pulling hard while some riskier names wobble. On the upside, Onto Innovation and TTM Technologies are rising, giving the fund a helpful tech tailwind, while Hecla and Coeur Mining add extra spark from the materials side. In health care, Guardant Health and Avidity Biosciences are more mixed, with Arrowhead Pharmaceuticals losing steam and Applied Digital still dragging due to weak fundamentals. Overall, it’s a U.S.-focused, broadly diversified small-cap play with no single sector dominating the stage.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HL	Hecla Mining Company	0.78%	$575.70K	$15.09B	363.38%	74 Outperform
CDE	Coeur Mining	0.64%	$472.65K	$13.12B	272.27%	69 Neutral
GH	Guardant Health	0.63%	$465.89K	$14.75B	142.74%	61 Neutral
ONTO	Onto Innovation	0.48%	$351.43K	$9.90B	4.08%	82 Outperform
TTMI	TTM Technologies	0.47%	$345.01K	$10.15B	292.51%	77 Outperform
AEIS	Advanced Energy	0.46%	$343.67K	$9.64B	121.90%	67 Neutral
RNA	Avidity Biosciences	0.44%	$325.84K	$10.94B	120.38%	62 Neutral
ARWR	Arrowhead Pharmaceuticals	0.44%	$323.00K	$9.71B	241.67%	57 Neutral
MOD	Modine	0.43%	$318.63K	$9.72B	72.48%	68 Neutral
APLD	Applied Digital Corporation	0.43%	$318.23K	$9.47B	415.85%	54 Neutral

STXK Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

34.02

Positive

100DMA

33.49

Positive

200DMA

31.72

Positive

Market Momentum

MACD

0.35

Positive

RSI

50.59

Neutral

STOCH

14.99

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For STXK, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 35.03, equal to the 50-day MA of 34.02, and equal to the 200-day MA of 31.72, indicating a neutral trend. The MACD of 0.35 indicates Positive momentum. The RSI at 50.59 is Neutral, neither overbought nor oversold. The STOCH value of 14.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for STXK.

STXK Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
STXK	―	―	$73.75M	0.18%	―
FSML	―	―	$99.55M	0.45%	―
AFSM	―	―	$77.46M	0.75%	―
FLQS	―	―	$71.58M	0.35%	―
BKSE	―	―	$65.52M	0.04%	―
SYZ	―	―	$59.79M	0.74%	―

Performance Comparison

STXK

Strive 2000 ETF

34.82

3.43

10.93%

FSML

Franklin Small Cap Enhanced ETF

―

AFSM

First Trust Active Factor Small Cap ETF

―

FLQS

Franklin LibertyQ U.S. Small Cap Equity ETF

―

BKSE

BNY Mellon US Small Cap Core Equity ETF

―

SYZ

Lazard US Systematic Small Cap Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents